Israeli Study Finds Pfizer Covid19 Booster Protects Against Omicron

  • Malaysia would be spending RM72.7 billion or 5% of its gross domestic product on healthcare this year, according to the finance minister, Tengku Zafrul Aziz
  • Earlier on, the World Health Organization had said that the expenditure on healthcare should be 7% of a nation’s GDP.

Israeli Study Finds Pfizer Covid19 Booster Protects Against Omicron

JERUSALEM (Reuters): Israeli researchers said on Saturday (Dec 12) that they found that a three-shot course of the Pfizer / BioNTech Covid-19 vaccine provided significant protection against the new Omicron variant.

The findings were similar to those presented by BioNTech and Pfizer earlier in the week, which were an early signal that booster shots could be key to protect against infection from the newly identified variant.

source- nikkei asia

The study, carried out by Sheba Medical Center and the Israeli Health Ministry’s Central Virology Laboratory, compared the blood of 20 people who had received two vaccine doses five to six months earlier to the same number of individuals who had received a booster a month before.

“People who received the second dose five or six months ago do not have any neutralisation ability against the Omicron while they do have some against the Delta (strain)," Gili Regev-Yochay, director of the Infectious Diseases Unit at Sheba, told reporters.

“The good news is that with the booster dose, it increases about a hundred fold. There is a significant protection of the booster dose. It is lower than the neutralisation ability against the Delta, about four times lower," she said.

The Israeli team said they worked with the actual virus while the companies used what is known as a pseudovirus, which was bio-engineered to have the hallmark mutations of Omicron.

Source: Reuters

Previous Post

WHO Expects Increase In Number Of Hospitalisations, Deaths From Omicron Coronavirus Strain

Next Post

VTL-Land Open To All Malaysian, Singaporean Citizens From Dec 20

Related Posts